Strain level and comprehensive microbiome analysis in inflammatory bowel disease via multi-technology meta-analysis identifies key bacterial influencers of disease

Simple item page
dc.contributor.authorRavichandar, Jayamary Divya
dc.contributor.authorRutherford, Erica
dc.contributor.authorChow, Cheryl-Emiliane T.
dc.contributor.authorHan, Andrew
dc.contributor.authorYamamoto, Mitsuko Lynn
dc.contributor.authorNarayan, Nicole R.
dc.contributor.authorKaplan, Gilaad G.
dc.contributor.authorBeck, Paul L.
dc.contributor.authorClaesson, Marcus J.
dc.contributor.authorDabbagh, Karim
dc.contributor.authorIwai, Shoko
dc.contributor.authorDeSantis, Todd Z.
dc.date.accessioned2022-11-10T09:31:16Z
dc.date.available2022-11-10T09:31:16Z
dc.date.issued2022
dc.date.updated2022-11-10T09:10:16Z
dc.description.abstractInflammatory bowel disease (IBD) is a heterogenous disease in which the microbiome has been shown to play an important role. However, the precise homeostatic or pathological functions played by bacteria remain unclear. Most published studies report taxa-disease associations based on single-technology analysis of a single cohort, potentially biasing results to one clinical protocol, cohort, and molecular analysis technology. To begin to address this key question, precise identification of the bacteria implicated in IBD across cohorts is necessary. We sought to take advantage of the numerous and diverse studies characterizing the microbiome in IBD to develop a multi-technology meta-analysis (MTMA) as a platform for aggregation of independently generated datasets, irrespective of DNA-profiling technique, in order to uncover the consistent microbial modulators of disease. We report the largest strain-level survey of IBD, integrating microbiome profiles from 3,407 samples from 21 datasets spanning 15 cohorts, three of which are presented for the first time in the current study, characterized using three DNA-profiling technologies, mapping all nucleotide data against known, culturable strain reference data. We identify several novel IBD associations with culturable strains that have so far remained elusive, including two genome-sequenced but uncharacterized Lachnospiraceae strains consistently decreased in both the gut luminal and mucosal contents of patients with IBD, and demonstrate that these strains are correlated with inflammation-related pathways that are known mechanisms targeted for treatment. Furthermore, comparative MTMA at the species versus strain level reveals that not all significant strain associations resulted in a corresponding species-level significance and conversely significant species associations are not always re-captured at the strain level. We propose MTMA for uncovering experimentally testable strain-disease associations that, as demonstrated here, are beneficial in discovering mechanisms underpinning microbiome impact on disease or novel targets for therapeutic interventions.en
dc.description.statusPeer revieweden
dc.description.versionPublished Versionen
dc.format.mimetypeapplication/pdfen
dc.identifier.citationRavichandar, J. D., Rutherford, E., Chow, C-E T., Han, A., Yamamoto, M. L., Narayan, N. R., Kaplan, G. G., Beck, P. L.; Claesson, M. J., Dabbagh, K., Iwai, S. and DeSantis, T. Z. (2022) 'Strain level and comprehensive microbiome analysis in inflammatory bowel disease via multi-technology meta-analysis identifies key bacterial influencers of disease', Frontiers In Microbiology, 13, (20pp). doi: 10.3389/fmicb.2022.961020en
dc.identifier.doi10.3389/fmicb.2022.961020en
dc.identifier.endpage20en
dc.identifier.issn1664-302X
dc.identifier.journaltitleFrontiers In Microbiologyen
dc.identifier.startpage1en
dc.identifier.urihttps://hdl.handle.net/10468/13844
dc.identifier.volume13en
dc.language.isoenen
dc.publisherFrontiers Media S.A.en
dc.rights© 2022 Ravichandar, Rutherford, Chow, Han, Yamamoto, Narayan, Kaplan, Beck, Claesson, Dabbagh, Iwai and DeSantis. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.en
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/en
dc.subjectMeta-analysisen
dc.subjectGut microbiomeen
dc.subjectInflammatory bowel diseaseen
dc.subjectMetagenomicsen
dc.subject16S rRNAen
dc.subjectStrainen
dc.titleStrain level and comprehensive microbiome analysis in inflammatory bowel disease via multi-technology meta-analysis identifies key bacterial influencers of diseaseen
dc.typeArticle (peer-reviewed)en
Files
Original bundle
Now showing 1 - 2 of 2
Thumbnail Image
Name:
fmicb-13-961020.pdf
Size:
9.94 MB
Format:
Adobe Portable Document Format
Description:
Published Version
Download
Thumbnail Image
Name:
6247758.zip
Size:
9.89 MB
Format:
http://www.iana.org/assignments/media-types/application/zip
Description:
Supplemental Data
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
2.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Microbiology - Journal Articles
APC Microbiome Ireland - Journal Articles